prof. dr. J.A. (Jourik) Gietema


prof. dr. J.A. (Jourik) Gietema


  1. Testicular cancer: Determinants of cisplatin sensitivity and novel therapeutic opportunities

    de Vries, G., Rosas-Plaza, X., van Vugt, M. A. T. M., Gietema, J. A. & de Jong, S., 1-Aug-2020, In : CANCER TREATMENT REVIEWS. 88, 12 p., 102054.

    Research output: Contribution to journalReview articleAcademicpeer-review

  2. Tumour biomarkers: association with heart failure outcomes

    Shi, C., van der Wal, H. H., Sillje, H. H. W., Dokter, M. M., van den Berg, F., Huizinga, L., Vriesema, M., Post, J., Anker, S. D., Cleland, J. G., Ng, L. L., Samani, N. J., Dickstein, K., Zannad, F., Lang, C. C., van Haelst, P. L., Gietema, J. A., Metra, M., Ameri, P., Canepa, M., van Veldhuisen, D. J., Voors, A. A. & de Boer, R. A., Aug-2020, In : Journal of Internal Medicine. 288, 2, p. 207-218 12 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Early ageing after cytotoxic treatment for testicular cancer and cellular senescence: Time to act

    Lubberts, S., Meijer, C., Demaria, M. & Gietema, J. A., Jul-2020, In : Critical Reviews in Oncology/Hematology. 151, 8 p., 102963.

    Research output: Contribution to journalReview articleAcademicpeer-review

View all (228) »

ID: 75154